Michael Carbonara - 24 Aug 2022 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (ZEOX)

Reporting relationship: Director
Issuer ticker: ZEOX
Reported as of: 24 Aug 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Aug 2022, 16:55:30 UTC
Source filing: View source filing
Reporting owner signature: /s/ Michael Carbonara

Key filing fact

Michael Carbonara filed Form 4 for Organicell Regenerative Medicine, Inc. (ZEOX) on 24 Aug 2022.

Key facts

This page summarizes Michael Carbonara's Form 4 filing for Organicell Regenerative Medicine, Inc. (ZEOX).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 24 Aug 2022, 16:55.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OCEL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 47,818,181
Date: 24 Aug 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Michael Carbonara is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

The Reporting Person is filing this Form 4 to report his resignation as a director of the Issuer effective August 19, 2022 and his beneficially owned holdings in the Issuer as of such date.